Betz Stephen F. bought CRNX
December 26, 2025 · Form 4 insider transaction
Betz Stephen F. bought 18,000 shares of Crinetics Pharmaceuticals Inc at $1.91 per share, a transaction worth $34.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,000
Price
$1.91
Total value
$34.4K
InsiderBetz Stephen F.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 26, 2025
Filing dateDecember 29, 2025
Shares owned after117,713
OwnershipDirect
10b5-1 planNo
AmendedNo